Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI.
about
Advances in HIV microbicide developmentThe regulation of inflammatory pathways and infectious disease of the cervix by seminal fluidBottlenecks in HIV-1 transmission: insights from the study of founder virusesPolyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infectionDirect visualization of HIV-enhancing endogenous amyloid fibrils in human semen.The Surprising Role of Amyloid Fibrils in HIV InfectionSeminal plasma induces global transcriptomic changes associated with cell migration, proliferation and viability in endometrial epithelial cells and stromal fibroblastsEffect of semen and seminal amyloid on vaginal transmission of simian immunodeficiency virusStructural characterization of semen coagulum-derived SEM1(86-107) amyloid fibrils that enhance HIV-1 infection.Liquefaction of semen generates and later degrades a conserved semenogelin peptide that enhances HIV infection.HIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins.The amyloidogenic SEVI precursor, PAP248-286, is highly unfolded in solution despite an underlying helical tendency.HIV-1 enhancing effect of prostatic acid phosphatase peptides is reduced in human seminal plasma.Semen amyloids participate in spermatozoa selection and clearanceInteraction of fibronectin with semen amyloids synergistically enhances HIV infection.Innate immunity against HIV: a priority target for HIV prevention researchProteomic identification of galectin-3 binding ligands and characterization of galectin-3 proteolytic cleavage in human prostasomesInvestigation of galectin-3 function in the reproductive tract by identification of binding ligands in human seminal plasmaInnate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection.Preventing mucosal HIV transmission with topical microbicides: challenges and opportunities.Semen protects CD4+ target cells from HIV infection but promotes the preferential transmission of R5 tropic HIVSemen enhances HIV infectivity and impairs the antiviral efficacy of microbicides.Discovery of modulators of HIV-1 infection from the human peptidome.Morphology-Dependent HIV-Enhancing Effect of Semen-Derived Enhancer of Viral Infection.Characterization of the Influence of Semen-Derived Enhancer of Virus Infection on the Interaction of HIV-1 with Female Reproductive Tract Tissues.Naturally occurring fragments from two distinct regions of the prostatic acid phosphatase form amyloidogenic enhancers of HIV infection.Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection.Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCGA Peptide Derived from the HIV-1 gp120 Coreceptor-Binding Region Promotes Formation of PAP248-286 Amyloid Fibrils to Enhance HIV-1 Infection.Seminal plasma accelerates semen-derived enhancer of viral infection (SEVI) fibril formation by the prostatic acid phosphatase (PAP248-286) peptide.A molecular tweezer antagonizes seminal amyloids and HIV infection.ADS-J1 inhibits semen-derived amyloid fibril formation and blocks fibril-mediated enhancement of HIV-1 infection.Amyloid formation: functional friend or fearful foe?Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils.Mucosal stromal fibroblasts markedly enhance HIV infection of CD4+ T cells.Epigallocatechin Gallate Inhibits Macaque SEVI-Mediated Enhancement of SIV or SHIV Infection.Core sequence of PAPf39 amyloid fibrils and mechanism of pH-dependent fibril formation: the role of monomer conformationNo SEVI-mediated enhancement of rectal HIV-1 transmission of HIV-1 in two humanized mouse cohortsShort communication: human immunodeficiency virus rebound in blood and seminal plasma following discontinuation of antiretroviral therapyImproving preclinical models of HIV microbicide efficacy.
P2860
Q26852858-4DEBA377-E986-4156-864E-68F5F2729A87Q27024447-BFAF7DF3-555F-4125-AAB1-3C455A6B32E4Q28082862-64AB16EE-08BE-4BD0-B60D-3DD4964186F6Q28489042-1388726F-D92A-4CAC-B7FE-5393652A45ECQ30360888-24F925BD-923B-4272-8C0A-F733B5C267E5Q33570363-61242FCF-6B2C-44A5-ABAE-FFF55FABF2CDQ33598471-72844949-A84C-4382-B820-D185870BC2E9Q33643272-9BF2DE72-16C4-4504-A2FF-19549102D90EQ33689504-3423AD51-2102-469C-986F-45A7D8EB36C0Q33744114-BC612A33-F32B-4B6D-BF98-EFCA4A3F3DF9Q33753950-E32191C7-F507-4FCF-AE0A-75077DE8AD92Q33801791-FDDC0B06-9450-4459-B674-0E62265B34D3Q33809334-886D575A-1765-4B31-BD83-7B03936A0FF7Q33842506-B9F9E215-8583-4DD1-8734-78E0F3C70967Q34209036-27914FF4-3A6D-4A1A-B05A-6FF5546E6614Q34243462-E545523C-F98B-4BB3-8100-286DF297A0A9Q34268051-A59E5BE8-EBC2-4FEB-AD71-1C362BD809ACQ34268107-3033961D-D623-478B-919F-747944FB1275Q34339797-44093167-3443-4C53-969C-BBF9CD053495Q34548621-F7A61E1C-0C90-4AA0-B051-0DE908B00B95Q34767047-5753B05E-88AE-427B-92F4-16E8D460AA3AQ35213456-2CB77E7F-1962-4A9C-9DB3-80E181D53F49Q35222585-19A6625F-C239-4AA3-A027-7890A9032743Q35530002-5E615036-C9D4-424D-9B95-2976DF7D2B5DQ35641451-3BC00208-3A95-4C88-AE39-EA49E269F4F7Q35665736-2DE272D3-8ECE-4903-9B37-4DB728FA3F4BQ35669283-E07082EE-1EF5-4A4D-B6BA-F7B96C8DEF6BQ35842343-CF59576B-5C21-4564-9D3F-2E671E649DA7Q35866200-FDE5B545-0ABD-4E30-8B05-F865C6B411F6Q35874384-2BBA7CC3-3D43-4484-9BCA-E7EA6A061512Q35954283-327C6A3F-140B-4BA7-A58C-263844ECD313Q35960654-9FD12F31-3166-4105-BE94-2B16DC9404E3Q36010357-3962CD58-CFCF-45D1-A257-898151975A7BQ36090859-9AEB005B-5754-4594-88FC-9FB3664C7543Q36283017-C6B15146-A5B3-431E-866E-AB2D5ACF42F2Q36318054-1934EA6C-F55D-4983-9065-4A9D87B5681EQ36546744-61034129-7A6E-453D-8A96-F2536B2ACD3DQ36553615-DF256B95-280A-4BB4-94A1-799F61626EB8Q36553934-260A2B15-6C5A-4EEC-99F2-7E7D643A4485Q36759002-3D56A496-89C1-481B-99C3-A92AA8A87D9C
P2860
Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Semen-mediated enhancement of ...... lates with the levels of SEVI.
@ast
Semen-mediated enhancement of ...... lates with the levels of SEVI.
@en
Semen-mediated enhancement of ...... lates with the levels of SEVI.
@nl
type
label
Semen-mediated enhancement of ...... lates with the levels of SEVI.
@ast
Semen-mediated enhancement of ...... lates with the levels of SEVI.
@en
Semen-mediated enhancement of ...... lates with the levels of SEVI.
@nl
prefLabel
Semen-mediated enhancement of ...... lates with the levels of SEVI.
@ast
Semen-mediated enhancement of ...... lates with the levels of SEVI.
@en
Semen-mediated enhancement of ...... lates with the levels of SEVI.
@nl
P2093
P2860
P50
P356
P1433
P1476
Semen-mediated enhancement of ...... lates with the levels of SEVI.
@en
P2093
Adam Burgener
Kyeong-Ae Kim
Ludger Staendker
Maral Yolamanova
Nadia R Roan
Onofrio Zirafi
Warner C Greene
Wolf-Georg Forssmann
P2860
P2888
P356
10.1186/1742-4690-7-55
P577
2010-06-23T00:00:00Z
P5875
P6179
1048608953